Credit Suisse’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Credit Suisse’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,135	Closed	-$733K	–	4122
2022 Q2	$733K	Buy	+13,135	New	+$779K	﹤0.01%	2591
2020 Q1	–	Sell	-2,939	Closed	-$608K	–	4088
2019 Q4	$608K	Sell	2,939 -151,092	-98%	-$27.9M	﹤0.01%	3445
2019 Q3	$23.5M	Sell	154,031 -16,131	-9%	-$2.64M	0.02%	817
2019 Q2	$21.9M	Sell	170,162 -34,937	-17%	-$4.14M	0.02%	872
2019 Q1	$24.2M	Buy	205,099 +6,884	+3%	+$694K	0.02%	758
2018 Q4	$18.2M	Buy	198,215 +7,839	+4%	+$795K	0.02%	838
2018 Q3	$21.4M	Buy	190,376 +65,094	+52%	+$6.88M	0.02%	834
2018 Q2	$11.5M	Sell	125,282 -57,087	-31%	-$5.54M	0.01%	1154
2018 Q1	$18.2M	Buy	182,369 +87,174	+92%	+$9.4M	0.02%	906
2017 Q4	$8.93M	Buy	95,195 +63,111	+197%	+$5.97M	0.01%	1357
2017 Q3	$3.26M	Buy	32,084 +4,084	+15%	+$357K	﹤0.01%	2134
2017 Q2	$2.14M	Buy	+28,000	New	+$2.36M	﹤0.01%	2184

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Credit Suisse's LKFT Position: Q3 2022 in Review

Credit Suisse sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2022, closing a stake of 13,135 shares — an estimated $733K sold.

Credit Suisse first reported a position in LKFT in Q2 2017 and held it in 12 quarters. The position peaked at $24.2M in Q1 2019. 83 funds tracked by Wall St. Rank hold LKFT as of Q3 2022.

Credit Suisse reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Credit Suisse sold 13,135 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2022, an estimated $733K.
Credit Suisse first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 12 quarters.
Credit Suisse's Lakefront Biotherapeutics American Depositary Shares position peaked at $24.2M in Q1 2019.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.